QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 xtant-medical-hldgs-raises-fy2025-sales-guidance-from-127000m-131000m-to-131000m-135000m-vs-129550m-est

Xtant Medical Hldgs (AMEX:XTNT) raises FY2025 sales outlook from $127.000 million-$131.000 million to $131.000 million-$135.000...

 xtant-medical-hldgs-q2-eps-002-beats-001-estimate-sales-30436m-miss-31350m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0...

 xtant-medical-holdings-announces-the-company-has-entered-into-agreements-to-sell-certain-coflex-and-cofix-interlaminar-stabilization-implant-assets-and-all-ous-entities-of-paradigm-spine-gmbh-to-companion-spine-llc-proceeds-of-transaction-total-192m

Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment o...

 xtant-medical-hldgs-raises-fy2025-sales-guidance-from-12600m-13000m-to-12700m-13100m-vs-12835m-est

Xtant Medical Hldgs (AMEX:XTNT) raises FY2025 sales outlook from $126.00 million-$130.00 million to $127.00 million-$131.00 mil...

 xtant-medical-hldgs-q1-sales-3290m-beat-3120m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly sales of $32.90 million which beat the analyst consensus estimate of $31.20 ...

 xtant-medical-hldgs-sees-fy2025-revenue-of-126000m-130000m-vs-13285m-est

Xtant Medical Hldgs (AMEX:XTNT) sees FY2025 sales of $126.000 million-$130.000 million vs $132.85 million analyst estimate.

 xtant-medical-hldgs-q4-eps-002-misses-001-estimate-sales-3151m-miss-3180m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $...

 xtant-medical-hldgs-affirms-fy2024-sales-guidance-from-11600m-12000m-to-11600m-12000m

Xtant Medical Hldgs (AMEX:XTNT) affirms FY2024 sales outlook from $116.00 million-120.00 million to $116.00 million-120.00 mill...

 xtant-medical-hldgs-q3-2024-gaap-eps-004-misses-003-estimate-sales-27937m-miss-29300m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $...

 xtant-medical-expands-product-portfolio-with-the-launch-of-the-cortera-posterior-fixation-system

New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION